Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Asset disposition
Acq. announced
Director departure
CC transcript
Inv. presentation
Jazz Pharmaceuticals plc (JAZZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2021 8-K/A Financial Statements and Exhibits  Interactive Data
Docs: "Consent of Deloitte & Touche LLP",
"Audited consolidated financial statements of GW as of and for the years ended December 31, 2020 and 2019, and the notes related thereto",
"Unaudited consolidated financial statements of GW as of March 31, 2021 and December 31, 2020 and for the three months ended March 31, 2021 and 2020, and the notes related thereto",
"Unaudited pro forma condensed combined financial statements as of and for the three months ended March 31, 2021 and for the year ended December 31, 2020, and the notes related thereto"
05/31/2016 8-K/A Investor presentation
Docs: "Investor Presentation"
03/31/2014 8-K/A Financial Statements and Exhibits
Docs: "Consent of Reconta Ernst & Young S.p.A",
"Audited consolidated financial statements of Gentium S.p.A as of December 31, 2013 and 2012 and for each of the three years in the period ended December 31, 2013, and the notes related thereto",
"Unaudited pro forma condensed combined financial information as of and for the year ended December 31, 2013 and the notes related thereto"
12/20/2013 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Tender Offer Agreement, by and among Jazz Pharmaceuticals Public Limited Company, Jazz Pharmaceuticals Italy S.r.l. and Gentium S.p.A",
"Form of Support Agreement"
08/10/2012 8-K/A Form 8-K/A - Current report [Amend]
02/20/2009 8-K/A Form 8-K/A - Current report [Amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy